Human epidermal growth factor receptor 2 (HER2) is a member of receptor tyrosine kinase of ERBB family, whose mutation has been reported in about 2%-3% of patients with lung adenocarcinomas [3]. The gene discussed is ERBB2; the disease is lung adenocarcinoma.